RUNX1T1 and neuroblastoma: To this end, we first screened the synthesized imidazo-pyrazole derivatives (IMPs) 4G and 4I (Figure 1) [19], on ETO-sensitive (HTLA-230) and ETO-resistant (HTLA-ER) NB cells.